Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HLCM051 (MultiStem) for ARDS
NCT03807804Phase 2Completed
- Sponsor
- Healios
- Start
- Jan 2019
- Primary completion
- Dec 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of invimestrocel in acute respiratory distress syndrome (ARDS), sponsored by Healios. Started Jan 2019; status: completed.
02
Drugs
invimestrocel
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT03807804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03807804.